CHEO Research Institute

Discoveries to inspire the best life for every child and youth.

The CHEO Research Institute is a not for profit corporation that connects exceptional talent and technology in pursuit of life-changing research for every child, youth and family in our community and beyond. We inspire trust in our research excellence by being curious, nimble, passionate and equitable.

Welcome and Strategic Overview

Welcome to the CHEO Research Institute

Learn more

World-first AI algorithm developed at CHEO leads to rare disease diagnosis for families

World-first AI algorithm developed at CHEO leads to rare disease diagnosis for families

Learn more

Bears’ Den Innovation Pitch Event

Bears Den Innovation Pitch Event

Learn more

Updates & News

  1. Dr. Bernard Thébaud Appointed Tier 1 Canada Research Chair in Lung Stem Cell Biology and Regeneration

    14/11/2024

    Dr. Bernard Thébaud Appointed Tier 1 Canada Research Chair in Lung Stem Cell Biology and Regeneration

  2. CHEO Hopes to Share World-First AI Algorithm to Diagnose Rare Disease

    13/11/2024

    CHEO Hopes to Share World-First AI Algorithm to Diagnose Rare Disease

  3. What’s the best snot sucker on the market? – Discovery Minute

    13/11/2024

    What’s the best snot sucker on the market? – Discovery Minute

Read More News

Latest Discoveries

  1. Virtual psychoeducation for improvement of pain catastrophizing in pediatric presurgical patients and caregivers: A proof-of-concept study

    03/10/2024

  2. Engaging community members to ensure culturally specific language is used in research: should I use gay, queer, MSM, or this other new acronym?

    04/09/2024

  3. Poster 246: Epidemiology of Tibial Spine Fractures in Children: A National Multicenter Study

    31/07/2024

  4. How Is Variability in Femoral and Acetabular Version Associated With Presentation Among Young Adults With Hip Pain?

    07/05/2024

  5. The evolving role and technique of hip arthroscopy in children and adolescents

    25/04/2024

  6. Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia

    03/04/2024